| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.061 | 0.05 |